ArticleSarcoma2013

Insulin-like growth factor 1 receptor as a therapeutic target in ewing sarcoma: lack of consistent upregulation or recurrent mutation and a review of the clinical trial literature.

Alison O'Neill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.